Navigation Links
Contract Research Organization, WCCT Global, Welcomes Gary Urban as Executive Director, Corporate Compliance and Quality
Date:2/18/2013

Costa Mesa, California (PRWEB) February 18, 2013

WCCT Global, a contract research organization (CRO) supporting Phase I - IV biopharmaceutical and device development headquartered in Southern California, today welcomes Gary Urban as Executive Director, Corporate Compliance and Quality. As a Contract Research Organization professional for the past 16 years, Gary has held executive-level positions with global responsibility for Quality Management Systems, Clinical and Corporate Operations, and Information Technology. Gary earned a Bachelor of Science in Business Administration with a concentration in international business from Colorado Technical University. Gary is also certified in Good Clinical Practice and Lean Six Sigma Black Belt. When asked how Gary felt to be joining WCCT Global, he replied, “I am extremely excited to have joined this dynamic and growing organization, and look forward to leveraging my background in organizational optimization, leading companies successfully through growth and change, while ensuring the highest levels of quality, efficiency, and client and associate satisfaction.”
This is another great addition to WCCT Global because the service offering that WCCT Global is providing continues to grow which is why WCCT Global is contacted by sponsors all over the world to perform clinical studies in many different therapeutic areas. WCCT Global’s Chief Operating Officer Jon Rojas says, “Gary’s experience in I.T. and quality assurance allows WCCT Global to bring new technology, ensuring quality within our organization which in turn expands the breadth of services that we can offer to our clients.”
WCCT Global is a multi-site, full service global contract research organization (CRO) of outsourced early drug development and late phase services to the pharmaceutical, biotechnology and medical device industries. The WCCT Global vision, “With compassion for people, we strive for tomorrow’s therapies to be available today” truly exemplifies the focus and reason for our cutting edge work both in our clinics and throughout our operations. As a drug development partner, WCCT Global collaborates with domestic and foreign innovator companies who need regulatory, program management, data management and strategic consulting support, with an emphasis on overseeing and executing trials in special disease populations, pediatric populations, ethno-bridging, and cardiac safety. WCCT has extensive experience with healthy volunteer studies including First-in-Human (FIH), as well as specific therapeutic expertise in Allergy, Asthma, HCV, Ophthalmology, Oncology, Renal, and Vaccines.
If you would like to request information about how WCCT Global can assist your organization with a clinical study, please CLICK HERE.

Read the full story at http://www.prweb.com/releases/2013/2/prweb10437942.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. PBM Experts to Discuss Non-Rate Contracting Terms in Feb. 25 Atlantic Information Services Webinar
2. MMS Group Explores New Opportunities for Placing Healthcare Contractors
3. EMR Staffing Partners Preparing for 25% Increase in Contract Staffing Business
4. Securityhunter, Inc. Selected as a Top 25 Baltimore Defense Contractor for the Baltimore Business Journal's 2013 Book of Lists
5. PLEXERA® LLC Launches Contract Research Services Business for Biomolecular Interaction Studies
6. NHS consultant contract fails to increase productivity
7. Care2Learn/Upstairs Solutions and Jarlette Health Services Sign Multi-Year Contract for Online Training and Record-Keeping
8. NIH awards Georgia malaria research consortium up to $19.4 million contract
9. Federal government renews contract for collecting and maintaining national stem cell transplantation database
10. BMC awarded contract to study validity of primary care drug screening tools
11. Collagenase for Dupuytrens contracture: Added benefit not proven
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2017)... ... June 24, 2017 , ... ... at the Sheraton Erie Bayfront and Erie Convention Center on June 8-10. ... exhibits, a student quiz bowl, award and scholarship presentations, and professional networking. ...
(Date:6/23/2017)... ... 23, 2017 , ... The Rhode Island Quality Institute (RIQI) ... and Dashboards, an innovative new service enabling healthcare providers to proactively coordinate care ... and Dashboards provide near real-time data about patients admitted to and/or discharged from ...
(Date:6/23/2017)... (PRWEB) , ... June 24, 2017 , ... Studies show ... significantly reduce the risk of visual loss in these patients. , But how often ... diet, or smoking cessation to patients at risk of or with early symptoms of ...
(Date:6/23/2017)... ... ... Everybody has their own personal preference when it comes to pornography. Some ... don't like it at all. FindaTopDoc took a look at what makes people attracted ... readers a taste of their deepest, darkest fantasies and has the ability to help ...
(Date:6/23/2017)... , ... June 23, 2017 , ... ... Cancer Conference from Sept. 18 to 20. , The two-day conference is focused ... with the goal of improving patients’ lives and eliminating racial breast cancer-related disparities. ...
Breaking Medicine News(10 mins):
(Date:6/13/2017)... June 13, 2017 Zimmer Biomet Holdings, Inc. (NYSE ... announced that the U.S. Food and Drug Administration (FDA) has ... 2015 relating to its Zhejiang, China ... "The successful clearance of the Warning Letter related ... facility is a measure of the progress we have made ...
(Date:6/11/2017)... and Company (NYSE: LLY ) announced today ... an investigational treatment for the prevention of episodic and ... endpoints for galcanezumab compared to placebo at both studied ... REGAIN) will be presented today at the American Headache ... . "The detailed Phase 3 ...
(Date:6/9/2017)... PALO ALTO, Calif. , June 9, 2017 /PRNewswire/ ... medical device company focused on the design, manufacture, sale ... updated the market on the progress of its commercial ... AeroForm is now available in more than one hundred ... country. AeroForm offers a needle-free alternative ...
Breaking Medicine Technology: